Top news of the week from Specialty Pharmacy Times.
5. Drug for Rare Form of Rickets Gets FDA Approval
Burosumab (Crysvita, Ultragenyx) is the first treatment approved for x-linked hypophosphatemia in adults and children ages 1 and older.
4. Study Sheds Light on How HIV Evades the Immune System
HIV targets and disables a pathway involved in blocking viral activity and clearing infection.
3. High Carbohydrate Diet May Increase Mortality Risk in Certain Cancers
The findings suggest that a patient’s diet may impact their ability to combat head and neck cancer.
2. Breakthrough Technique Improves Precision of Gene-Editing Technology
A synthetic bridged nucleic acid was found to greatly improve the accuracy of gene-editing technology, which could potentially lead to new therapies for genetic diseases.
1. New Technology Could Advance Precision Medicine for Cancer, Neurological Disorders
The new method indexes thousands of cells simultaneously and could potentially improve understanding of various diseases at a molecular level.